Medication info

Esome-D 40mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationExpired
Ingredient · strength
Esomeprazole Magnesium Dihydrate›Strength being verified
Manufacturer / importer
SPC Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
28 tablets (14 tablets/ALU-ALU*2)
Approval status
Expired

MFDS item code 201803570 · Approved 2018.08.31

This product's status changed to Expired on 2023.08.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastroesophageal reflux disease, gastrointestinal disorders (ulcers, eradication therapy, etc.), and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water and must not be chewed or crushed. Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes may be controlled by administering 20 mg once daily. In adults, 20 mg once daily may be taken as needed. As-needed use is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies lasting longer than 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks after induction of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection. No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years or older — Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Adolescents aged 12 years or older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents aged 12 years or older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes may be controlled by administering 20 mg once daily. Children under 12 years — There is no experience with administration of this medicine to children under 12 years.

Ingredients

Manufacturer
SPC Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, gastrointestinal disorders (ulcers, eradication therapy, etc.), and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat gastroesophageal reflux disease and erosive esophagitis, and can also be used for long-term maintenance therapy to prevent recurrence in patients with esophagitis. Additionally, it is effectively used in combination with antibiotics for the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. It treats upper gastrointestinal symptoms and gastric ulcers caused by the use of nonsteroidal anti-inflammatory drugs and helps prevent gastric ulcers and duodenal ulcers in patients for whom such medication is unavoidable. It is also applicable in the treatment of Zollinger-Ellison syndrome and the maintenance therapy for the prevention of rebleeding of gastric and duodenal ulcers post-intravenous administration. Overall, this medication is used for the treatment and prevention of various gastrointestinal diseases and related symptoms.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water and must not be chewed or crushed. Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes may be controlled by administering 20 mg once daily. In adults, 20 mg once daily may be taken as needed. As-needed use is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies lasting longer than 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks after induction of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection. No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years or older — Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Adolescents aged 12 years or older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents aged 12 years or older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes may be controlled by administering 20 mg once daily. Children under 12 years — There is no experience with administration of this medicine to children under 12 years.

Precautions

This medication should not be administered to certain patients. For example, patients who are allergic to this medication or any of its components, or who have had hypersensitivity reactions to benzimidazole derivatives, should not take it. Additionally, it should not be used if there is an allergy to specific antibiotics that are used together during Helicobacter pylori eradication therapy. Furthermore, patients with a history of certain heart diseases or nursing mothers should also refrain from taking this medication. This medication can cause various adverse reactions, so careful monitoring for any abnormal symptoms in the body during use is necessary. Adverse effects such as blood-related problems, allergic reactions, neurological symptoms, gastrointestinal disorders, liver function abnormalities, and skin rashes have been reported. In particular, if muscle pain or weakness occurs, it may indicate a serious condition called rhabdomyolysis, and immediate consultation with a healthcare professional is required. Regular testing is necessary for long-term use of this medication, and if symptoms indicate malignant tumors, it must only be administered after consulting a specialist. Additionally, this medication may suppress gastric acid secretion, which can affect the normal flora balance in the stomach, increasing the risk of infection. If diarrhea persists, it should be reported to the healthcare professional. This medication has a high potential for drug interactions, so if other medications are being taken, the physician or pharmacist must be informed. For instance, caution is needed when taking it with blood thinners, antiviral medications, or antibiotics. Pregnant or nursing women should consult a physician before taking this medication, as special precautions are necessary. In cases of overdose, there is no specific antidote available, so immediate medical attention should be sought, and it should be stored out of reach of children.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, xerostomia, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, substernal chest pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsening of constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, worsening of depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorder, tremors, visual field loss, dysmenorrhea, menstrual disorders, vulvitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, dysosmia, ageusia, parageusia, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric gland polyp, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is also advisable to store it at room temperature, between 1 degree and 30 degrees Celsius, avoiding excessively hot or cold conditions.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

28 tablets (14 tablets/ALU-ALU*2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.